Testing effectiveness (Phase 2)Study completedNCT02756650
What this trial is testing
1 Year of Treatment With Canakinumab in Behçet's Disease Patients With Neurologic or Vascular Involvement
Who this might be right for
Behcet Disease
Novartis Pharmaceuticals 8